Physician profile
Michelle Heller
NPI 1710156799
$1,983.06
in general payments reported to CMS, 2019-2025
16 companies · $261 in 2025
The $261 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $241 · 2021: $232 · 2022: $258 · 2023: $302 · 2024: $350 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $419.14 | 2019-2025 | |
| Glaxosmithkline, LLC. | $349.80 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Alk-Abello, INC | $220.99 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Merck Sharp & Dohme LLC | $204.77 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Kaleo, INC. | $186.15 | 2019-2023 | Auvi-Q |
| Cranial Technologies, INC | $164.37 | 2019-2025 | Doc Band |
| Qiagen, LLC | $95.73 | 2020 | |
| Tris Pharma INC | $88.17 | 2020-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $55.58 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $45.65 | 2020 | |
| Aytu Biopharma, INC. | $38.46 | 2021-2024 | |
| Ars Pharmaceuticals Operations, INC. | $31.60 | 2025 | Neffy |
| Dermira, INC. | $28.84 | 2020 | |
| Shire North American Group INC | $24.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.44 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.